跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VEKLURY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VEKLURY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
VEKLURY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Gilead Sciences Ireland Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 13, 2020
Approval ID
d6a9083be4d5d521
Company
Gilead Sciences Ireland Unlimited Company
Type
Standard
Approval Details
Approval Id
d6a9083be4d5d521
Drug Cima Aemps Name
VEKLURY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1201459002
Holder Company Name
Gilead Sciences Ireland Unlimited Company
Marketing Company Name
Gilead Sciences S.L.
Holder Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Authorization Date
2020-07-13
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Gilead Sciences Ireland Unlimited Company
Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
Gilead Sciences Ireland Unlimited Company
Name En
Gilead Sciences Ireland Unlimited Company
Country Name
Ireland
City Name
carrigtwohill,country_ie
Address
Ida Business & Technology Park
Active Ingredients
REMDESIVIR
105 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 13, 2020
Approval ID
d6a9083be4d5d521
Type
Standard
Back to CIMA-AEMPS Approvals